# Growth Hormone Use in Cystic Fibrosis - a Multicenter Study

> **NCT00005112** · PHASE3 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)**

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Human recombinant growth hormone

## Key facts

- **NCT ID:** NCT00005112
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005112, "Growth Hormone Use in Cystic Fibrosis - a Multicenter Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00005112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*